.jpg)
Features
November 14, 2023
NLA 2024 Nominations Open
Nominations open November 15, 2023 for the National Lipid Association Board of Directors and Chapter officers and will...
Read More...September 29, 2023
Ionis announces positive olezarsen topline results from Phase 3 study in people with familial chylomicronemia syndrome
Ionis announced positive topline results for the Phase 3 Balance study of olezarsen in people with familial...
Read More...September 5, 2023
NLA Responds to the USPSTF Recommendation Statement on Screening Lipid Panel in Children and Adolescents
The United States Preventive Services Task Force (USPSTF) recently released its Final Recommendation Statement on...
Read More...July 13, 2023
Novartis Receives FDA Approval for Label Update On Use of Leqvio (Inclisiran)
Novartis received FDA approval for a label update that will allow for use of Leqvio ® (inclisiran) in certain patients...
Read More...June 3, 2023
Nutrition interventions for adults with dyslipidemia: A Clinical Perspective from the National Lipid Association
Lifestyle habits can have a profound impact on atherosclerotic cardiovascular disease (ASCVD) risk. The National...
Read More...